anic Blog

anicomply at the 19th Official GAMP® 5 Conference

Electronic batch recording. Pragmatically validated.

After PHARMA MES Europe in Berlin, we are heading to Mannheim in December: at the 19th Official GAMP® 5 Conference, we will show how anicomply digitally maps regulated process steps, guides users through their tasks and documents process data in a traceable way.

The focus is on a question that matters especially at the GAMP® 5 Conference: how does a digital batch process become a validated system in operation – without turning into a multi-year project?

Visit us at Booth 8 and talk to us about your batch process.: anicomply at the 19th Official GAMP® 5 Conference

Rethinking ELN and LIMS: Why anicomply Is the More Flexible Path to Controlled Lab Digitalization

Laboratory managers, IT business partners and technical management know the problem: the SOP is stored in Word, execution happens on paper or in Excel, and every change to a method means weeks of effort — ticketing, vendor coordination and revalidation. Traditional ELN and LIMS systems often adapt processes only slowly and rigidly. What is missing is a system that can directly take over existing Word documents and immediately turn them into executable, controlled workflows.

This is exactly what anicomply does.

Read article: Rethinking ELN and LIMS: Why anicomply Is the More Flexible Path to Controlled Lab Digitalization

The Path to the Agile Lab: Why Traditional EBR Systems Are Slowing Down the Pharmaceutical Industry—and How to Break Free

Why do recipe changes in your production still take months? While the market demands agility, rigid EBR systems slow down innovation. Discover how to break free from the "golden cage"—from paper chaos through digital bottlenecks to true production agility in hours instead of quarters.

A way out of the dilemma?: The Path to the Agile Lab: Why Traditional EBR Systems Are Slowing Down the Pharmaceutical Industry—and How to Break Free

Audit Trail Review in Practice

Audit trail reviews are more than a compliance exercise – they are crucial for data integrity and compliance in pharmaceutical production. However, many companies face challenges in practice: confusing raw data, missing filters, and time-consuming manual reviews.

Read article: Audit Trail Review in Practice – What Really Matters?

anicomply at PHARMA MES Europe 2026

A short demo. Clear answers for your batch process.

At PHARMA MES Europe 2026, we will show you how anicomply digitally maps regulated process steps, guides users through their tasks and documents process data in a traceable way.

A product demo does not have to be long to answer the decisive questions. The presentation focuses on the essentials. In a short time, you gain a clear insight into the digital flow of a batch process and see directly where anicomply can support your existing processes.

Our review: the key takeaways from PHARMA MES Europe 2026 in Berlin.: anicomply at PHARMA MES Europe 2026

Agile Upscaling in the Pharmaceutical Industry

Agile upscaling in the pharmaceutical industry: How anicomply revolutionizes digital documentation and supports GxP-compliant processes flexibly and efficiently.

Read article: Agile Upscaling in the Pharmaceutical Industry: How anicomply Revolutionizes Digitalization

Excellence in Manufacturing – Validation of computer systems for use in pharmaceutical production – Part 1

Computer System Validation (CSV) plays a central role in regulated industries such as pharmaceuticals, biotechnology, and medical technology. The focus is on patient safety, product quality, and data integrity, as well as operational efficiency and regulatory compliance.

Read article: Excellence in Manufacturing – Validation of computer systems for use in pharmaceutical production – Part 1

Flexible EBR in the regulated pharmaceutical environment – GxP-compliant and future-proof

The pharmaceutical industry is facing major challenges: Strict regulations (validation, ER/ES, audit trail, data integrity, data consistency, etc.) must be met, while at the same time customers expect innovation, fast delivery times and a broad product range – all while maintaining consistently high, defined quality.

What if the first step to solving your challenges could be found in this article?

Read article: Flexible EBR in the regulated pharmaceutical environment – GxP-compliant and future-proof